Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment

Human Molecular Genetics

Volumn 19, Issue 23, 2010, Pages 4587-4594

  Mertens, Jasmin ^a   Ramadori, Giuliano ^a   Mihm, Sabine ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; RNA POLYMERASE II;

ADULT; ALLELE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOMICS; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS;

ADULT; ALLELES; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION; GENETIC VARIATION; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTOR-1; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHOSPHOSERINE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 78149260345     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq386     Document Type: Article

References (39)

1. Lazarus, R., Vercelli, D., Palmer, L.J., Klimecki, W.J., Silverman, E.K., Richter, B., Riva, A., Ramoni, M., Martinez, F.D., Weiss, S.T. et al. (2002) Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol. Rev., 190, 9-25.
2. Hill, A.V. (2006) Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet., 40, 469-486.
3. Misch, E.A. and Hawn, T.R. (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin. Sci. (Lond.), 114, 347-360.
4. Taniguchi, T., Ogasawara, K., Takaoka, A. and Tanaka, N. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol., 19, 623-655.
5. Tamura, T., Yanai, H., Savitsky, D. and Taniguchi, T. (2008) The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol., 26, 535-584.
6. Zhou, F. (2009) Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol., 28, 239-260.
7. Ball, T.B., Ji, H., Kimani, J., McLaren, P., Marlin, C., Hill, A.V. and Plummer, F.A. (2007) Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS, 21, 1091-1101.
8. Ji, H., Ball, T.B., Ao, Z., Kimani, J., Yao, X. and Plummer, F.A. (2010) Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1. Scand. J. Infect. Dis., 42, 389-394.
9. Wietzke-Braun, P., Maouzi, A.B., Manhardt, L.B., Bickeboller, H., Ramadori, G. and Mihm, S. (2006) Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. Eur. J. Gastroenterol. Hepatol., 18, 991-997.
10. Saito, H., Tada, S., Wakabayashi, K., Nakamoto, N., Takahashi, M., Nakamura, M., Ebinuma, H. and Ishii, H. (2002) The detection of IRF-1 promoter polymorphisms and their possible contribution to T helper 1 response in chronic hepatitis C. J. Interferon Cytokine Res., 22, 693-700.
11. Fortunato, G., Calcagno, G., Bresciamorra, V., Salvatore, E., Filla, A., Capone, S., Liguori, R., Borelli, S., Gentile, I., Borrelli, F. et al. (2008) Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J. Interferon Cytokine Res., 28, 141-152.
12. Hudson, T.J. (2003) Wanted: regulatory SNPs. Nat. Genet., 33, 439-440.
13. Buckland, P.R. (2006) The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim. Biophys. Acta, 1762, 17-28.
14. Venters, B.J. and Pugh, B.F. (2009) How eukaryotic genes are transcribed. Crit. Rev. Biochem. Mol. Biol., 44, 117-141.
15. Buratowski, S. (2009) Progression through the RNA polymerase II CTD cycle. Mol. Cell, 36, 541-546.
16. Knight, J.C., Keating, B.J., Rockett, K.A. and Kwiatkowski, D.P. (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet., 33, 469-475.
17. Pastinen, T., Ge, B. and Hudson, T.J. (2006) Influence of human genome polymorphism on gene expression. Hum. Mol. Genet., 15(Review Issue 1), R9-R16.
18. Mertens, J., Bregadze, R., Mansur, A., Askar, E., Bickeboller, H., Ramadori, G. and Mihm, S. (2009) Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity. J. Mol. Med., 87, 815-824.
19. Chapman, R.D., Heidemann, M., Albert, T.K., Mailhammer, R., Flatley, A., Meisterernst, M., Kremmer, E. and Eick, D. (2007) Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science, 318, 1780-1782.
20. Egloff, S., O'Reilly, D., Chapman, R.D., Taylor, A., Tanzhaus, K., Pitts, L., Eick, D. and Murphy, S. (2007) Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression. Science, 318, 1777-1779.
21. Akhtar, M.S., Heidemann, M., Tietjen, J.R., Zhang, D.W., Chapman, R.D., Eick, D. and Ansari, A.Z. (2009) TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol. Cell, 34, 387-393.
22. Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R. and Young, R.A. (2007) A chromatin landmark and transcription initiation at most promoters in human cells. Cell, 130, 77-88.
23. Muse, G.W., Gilchrist, D.A., Nechaev, S., Shah, R., Parker, J.S., Grissom, S.F., Zeitlinger, J. and Adelman, K. (2007) RNA polymerase is poised for activation across the genome. Nat. Genet., 39, 1507-1511.
24. Hargreaves, D.C., Horng, T. and Medzhitov, R. (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell, 138, 129-145.
25. Saito, H., Tada, S., Ebinuma, H., Wakabayashi, K., Takagi, T., Saito, Y., Nakamoto, N., Kurita, S. and Ishii, H. (2001) Interferon regulatory factor 1 promoter polymorphism and response to type 1 interferon. J. Cell. Biochem., 81(Suppl. 36), 191-200.
26. Schedel, M., Pinto, L.A., Schaub, B., Rosenstiel, P., Cherkasov, D., Cameron, L., Klopp, N., Illig, T., Vogelberg, C., Weiland, S.K. et al. (2008) IRF-1 gene variations influence IgE regulation and atopy. Am. J. Respir. Crit. Care Med., 177, 613-621.
27. Aidery, P., Ramadori, G. and Mihm, S. (2007) Increased IRF-1 and IFN-a gene expression in chronic hepatitis C G-300A IRF-1 promoter polymorphism A allele carriers. Hepatology, 46, 448A.
28. Pastinen, T., Ge, B., Gurd, S., Gaudin, T., Dore, C., Lemire, M., Lepage, P., Harmsen, E. and Hudson, T.J. (2005) Mapping common regulatory variants to human haplotypes. Hum. Mol. Genet., 14, 3963-3971.
29. Serre, D., Gurd, S., Ge, B., Sladek, R., Sinnett, D., Harmsen, E., Bibikova, M., Chudin, E., Barker, D.L., Dickinson, T. et al. (2008) Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet., 4, e1000006.
30. Buckland, P.R. (2004) Allele-specific gene expression differences in humans. Hum. Mol. Genet., 13(Review Issue 2), R255-R260.
31. Rockman, M.V. and Wray, G.A. (2002) Abundant raw material for cis-regulatory evolution in humans. Mol. Biol. Evol., 19, 1991-2004.
32. Southam, L., Rodriguez-Lopez, J., Wilkins, J.M., Pombo-Suarez, M., Snelling, S., Gomez-Reino, J.J., Chapman, K., Gonzalez, A. and Loughlin, J. (2007) An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet., 16, 2226-2232.
33. Bray, N.J., Jehu, L., Moskvina, V., Buxbaum, J.D., Dracheva, S., Haroutunian, V., Williams, J., Buckland, P.R., Owen, M.J. and O'Donovan, M.C. (2004) Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum. Mol. Genet., 13, 2885-2892.
34. Fogarty, M.P., Xiao, R., Prokunina-Olsson, L., Scott, L.J. and Mohlke, K.L. (2010) Allelic expression imbalance at high-density lipoprotein cholesterol locus MMAB-MVK. Hum. Mol. Genet., 19, 1921-1929.
35. Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. and Kinzler, K.W. (2002) Allelic variation in human gene expression. Science, 297, 1143.
36. Rose, A.B. (2008) Intron-mediated regulation of gene expression. Curr. Top Microbiol. Immunol., 326, 277-290.
37. Mihm, S., Frese, M., Meier, V., Wietzke-Braun, P., Scharf, J.G., Bartenschlager, R. and Ramadori, G. (2004) Interferon type I gene expression in chronic hepatitis C. Lab. Invest., 84, 1148-1159.
38. Palancade, B. and Bensaude, O. (2003) Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur. J. Biochem., 270, 3859-3870.
39. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.